Clinical Trials in Georgia

Showing 10881-10900 of 19,050 trials

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

NCT01373086

This study will assess the efficacy and safety of LFF269 compared to placebo after treatment in subjects with essential hypertension.

Hypertension

Novartis Pharmaceuticals19 participantsStarted May 2011

Anaheim, California, United States • Fort Myers, Florida, United States • Miramar, Florida, United States +8 more locations

COMPLETEDPhase 365 miles

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

NCT01425723

The primary objective of the study is to evaluate the long-term safety of rFIXFc in participants with hemophilia B. The secondary objective of this study is to evaluate the efficacy of rFIXFc in the prevention and treatment of bleeding episodes.

Severe Hemophilia B

Bioverativ Therapeutics Inc.120 participantsStarted Dec 2011

Phoenix, Arizona, United States • Sacramento, California, United States • Aurora, Colorado, United States +46 more locations

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

Find Trials by Condition in Georgia

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults

Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors

A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors

Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

A Biobehavioral Intervention for Young Men With Testicular Cancer

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.